Matthew L. Sherman, EVP & Chief Medical Officer at ACCELERON PHARMA INC (XLRN), sold 6,000 shares at $22.69 ($140K) on 2015-10-15, disclosed to the SEC on 2015-10-16.
Scheduled sale ($140k) by EVP & Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.66 | 2,400 | $54K | 38.9% |
| 2 | $22.69 | 700 | $16K | 11.4% |
| 3 | $23.93 | 2,400 | $57K | 41.1% |
| 4 | $23.94 | 500 | $12K | 8.6% |
| Total | $23.28 avg | 6,000 | $140K | 100% |
| Filing → |
| DCPH | SELL | 2023-12-14 | $43K | — | Filing → |
| DCPH | SELL | 2023-10-31 | $28K | — | Filing → |
| DCPH | SELL | 2023-10-04 | $37K | — | Filing → |